He JT, et al. Mol. Cell. Proteom. (2012) cited as Ref 679 in DOI: 10.1038/s41392-020-0110-5 (Q9942)
Revision as of 15:49, 21 May 2020 by Admin (talk | contribs) (Created claim: Property:P105: M111.010744-, #quickstatements; #temporary_batch_1590074839150)
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
He JT, et al. Mol. Cell. Proteom. (2012) cited as Ref 679 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
He JT
0 references
2012
0 references
Mol. Cell. Proteom.
0 references
11
0 references
CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays (English)
0 references
M111.010744-
0 references
